The Short Version
The 83% figure comes from one 2024 cohort study of adults aged 50+ using a specific proxy definition of sarcopenic obesity. However, the claim presents this as a general fact. Larger meta-analyses pooling over 50,000 participants across dozens of studies consistently find a smaller increased mortality risk of roughly 21–24%. While sarcopenic obesity is genuinely associated with higher death risk, the 83% figure is a population-specific estimate, not a broadly established benchmark.